ArticleCancers2019

EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.

Zimam Mahmud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.